Cathelicidin administration protects mice from Bacillus anthracis spore challenge

Journal of Immunology

Volumn 181, Issue 7, 2008, Pages 4989-5000

  Lisanby, Mark W ^a   Swiecki, Melissa K ^a   Dizon, Brian L P ^a   Pflughoeft, Kathryn J ^b   Koehler, Theresa M ^b   Kearney, John F ^a,c  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c Shelby Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; CAP18 LIPOPOLYSACCHARIDE BINDING PROTEIN; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL GROWTH; BACTERIAL OVERGROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; C57BL 6 MOUSE; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; GROWTH INHIBITION; IMMUNITY; IN VITRO STUDY; INFECTION PREVENTION; INNATE IMMUNITY; MICROCAPSULE; MOUSE; NEUTROPHIL; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; SPORE GERMINATION; TRANSMISSION ELECTRON MICROSCOPY; A J MOUSE; ANIMAL; BACTERIAL SPORE; C57BL MOUSE; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MICROBIOLOGY; MORTALITY; PATHOGENICITY; SUBCUTANEOUS DRUG ADMINISTRATION; SWINE; VIRULENCE;

ANIMALS; ANTHRAX; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACILLUS ANTHRACIS; FEMALE; HUMANS; IMMUNITY, INNATE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED A; MICE, INBRED C57BL; SPORES, BACTERIAL; SWINE; VIRULENCE;

EID: 58149280836     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.7.4989     Document Type: Article

References (75)

1. Ganz, T. 2003. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3: 710-720. (Pubitemid 41070812)
2. Yang, D., O. Chertov, and J. J. Oppenheim. 2001. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J. Leukocyte Biol. 69: 691-697. (Pubitemid 32466405)
3. Jenssen, H., P. Hamill, and R. E. Hancock. 2006. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19: 491-511.
4. Finlay, B. B., and R. E. Hancock. 2004. Can innate immunity be enhanced to treat microbial infections? Nat. Rev. Microbiol. 2: 497-504.
5. Hancock, R. E., and G. Diamond. 2000. The role of cationic antimicrobial peptides in innate host defenses. Trends Microbiol. 8: 402-410.
6. Welling, M. M., P. S. Hiemstra, M. T. van den Barselaar, A. Paulusma-Annema, P. H. Nibbering, E. K. Pauwels, and W. Calame. 1998. Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation. J. Clin. Invest. 102: 1583-1590.
7. Steinberg, D. A., M. A. Hurst, C. A. Fujii, A. H. Kung, J. F. Ho, F. C. Cheng, D. J. Loury, and J. C. Fiddes. 1997. Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob. Agents Chemother. 41: 1738-1742.
8. Steinstraesser, L., R. D. Klein, A. Aminlari, M. H. Fan, V. Khilanani, D. G. Remick, G. L. Su, and S. C. Wang. 2001. Protegrin-1 enhances bacterial killing in thermally injured skin. Crit. Care Med. 29: 1431-1437. (Pubitemid 32641809)
9. Scott, M. G., E. Dullaghan, N. Mookherjee, N. Glavas, M. Waldbrook, A. Thompson, A. Wang, K. Lee, S. Doria, P. Hamill, et al. 2007. An anti-infective peptide that selectively modulates the innate immune response. Nat. Biotechnol. 25: 465-472. (Pubitemid 46572850)
10. Mock, M., and A. Fouet. 2001. Anthrax. Annu. Rev. Microbiol. 55: 647-671. (Pubitemid 32978119)
11. Dixon, T. C., M. Meselson, J. Guillemin, and P. C. Hanna. 1999. Anthrax. N. Engl. J. Med. 341: 815-826.
12. Guidi-Rontani, C. 2002. The alveolar macrophage: the Trojan horse of Bacillus anthracis. Trends Microbiol. 10: 405-409. (Pubitemid 35246267)
13. Cleret, A., A. Quesnel-Hellmann, A. Vallon-Eberhard, B. Verrier, S. Jung, D. Vidal, J. Mathieu, and J. N. Tournier. 2007. Lung dendritic cells rapidly mediate anthrax spore entry through the pulmonary route. J. Immunol. 178: 7994-8001. (Pubitemid 46898070)
14. Baldari, C. T., F. Tonello, S. R. Paccani, and C. Montecucco. 2006. Anthrax toxins: a paradigm of bacterial immune suppression. Trends Immunol. 27: 434-440.
15. Fukao, T. 2004. Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity. Lancet Infect Dis. 4: 166-170. (Pubitemid 38293140)
16. Raymond, B., D. Leduc, L. Ravaux, R. L. Goffic, T. Candela, M. Raymondjean, P. L. Goossens, and L. Touqui. 2007. Edema toxin impairs anthracidal phospholipase A2 expression by alveolar macrophages. PLoS Pathog. 3: e187.
17. Hu, H., Q. Sa, T. M. Koehler, A. I. Aronson, and D. Zhou. 2006. Inactivation of Bacillus anthracis spores in murine primary macrophages. Cell Microbiol. 8: 1634-1642. (Pubitemid 44350022)
18. Ruthel, G., W. J. Ribot, S. Bavari, and T. A. Hoover. 2004. Time-lapse confocal imaging of development of Bacillus anthracis in macrophages. J. Infect. Dis. 189: 1313-1316. (Pubitemid 38457258)
19. Kang, T. J., M. J. Fenton, M. A. Weiner, S. Hibbs, S. Basu, L. Baillie, and A. S. Cross. 2005. Murine macrophages kill the vegetative form of Bacillus anthracis. Infect. Immun. 73: 7495-7501.
20. Mayer-Scholl, A., R. Hurwitz, V. Brinkmann, M. Schmid, P. Jungblut, Y. Weinrauch, and A. Zychlinsky. 2005. Human neutrophils kill Bacillus anthracis. PLoS Pathog. 1: e23.
21. Pickering, A. K., M. Osorio, G. M. Lee, V. K. Grippe, M. Bray, and T. J. Merkel. 2004. Cytokine response to infection with Bacillus anthracis spores. Infect. Immun. 72: 6382-6389. (Pubitemid 39425419)
22. Cote, C. K., N. Van Rooijen, and S. L. Welkos. 2006. Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection. Infect. Immun. 74: 469-480.
23. Cote, C. K., K. M. Rea, S. L. Norris, N. van Rooijen, and S. L. Welkos. 2004. The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores. Microb. Pathog. 37: 169-175.
24. Lehrer, R. I., and T. Ganz. 2002. Cathelicidins: a family of endogenous antimicrobial peptides. Curr. Opin. Hematol. 9: 18-22.
25. Albrecht, M. T., H. Li, E. D. Williamson, C. S. Lebutt, H. C. Flick-Smith, C. P. Quinn, H. Westra, D. Galloway, A. Mateczun, S. Goldman, H. Groen, and L. W. Baillie. 2007. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax. Infect. Immun. 75: 5425-5433.
26. Kim, C., N. Gajendran, H. W. Mittrucker, M. Weiwad, Y. H. Song, R. Hurwitz, M. Wilmanns, G. Fischer, and S. H. Kaufmann. 2005. Human α-defensins neutralize anthrax lethal toxin and protect against its fatal consequences. Proc. Natl. Acad. Sci. USA 102: 4830-4835. (Pubitemid 40471539)
27. Kozel, T. R., W. J. Murphy, S. Brandt, B. R. Blazar, J. A. Lovchik, P. Thorkildson, A. Percival, and C. R. Lyons. 2004. mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia. Proc. Natl. Acad. Sci. USA 101: 5042-5047.
28. Pelat, T., M. Hust, E. Laffly, F. Condemine, C. Bottex, D. Vidal, M. P. Lefranc, S. Dubel, and P. Thullier. 2007. High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation. Antimicrob. Agents Chemother. 51: 2758-2764. (Pubitemid 47206210)
29. Piris-Gimenez, A., M. Paya, G. Lambeau, M. Chignard, M. Mock, L. Touqui, and P. L. Goossens. 2005. In vivo protective role of human group IIa phospholipase A2 against experimental anthrax. J. Immunol. 175: 6786-6791. (Pubitemid 41598923)
30. Schuch, R., D. Nelson, and V. A. Fischetti. 2002. A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 418: 884-889. (Pubitemid 34966308)
31. Scorpio, A., D. J. Chabot, W. A. Day, K. O'Brien, D. N. J. Vietri, Y. Itoh, M. Mohamadzadeh, and A. M. Friedlander. 2007. Poly--glutamate capsule-degrading enzyme treatment enhances phagocytosis and killing of encapsulated Bacillus anthracis. Antimicrob. Agents Chemother. 51: 215-222. (Pubitemid 46047709)
32. Shoop, W. L., Y. Xiong, J. Wiltsie, A. Woods, J. Guo, J. V. Pivnichny, T. Felcetto, B. F. Michael, A. Bansal, R. T. Cummings, et al. 2005. Anthrax lethal factor inhibition. Proc. Natl. Acad. Sci. USA 102: 7958-7963.
33. Wang, W., C. Mulakala, S. C. Ward, G. Jung, H. Luong, D. Pham, A. J. Waring, Y. Kaznessis, W. Lu, K. A. Bradley, and R. I. Lehrer. 2006. Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin. J. Biol. Chem. 281: 32755-32764. (Pubitemid 46036831)
34. Drysdale, M., A. Bourgogne, S. G. Hilsenbeck, and T. M. Koehler. 2004. atxA controls Bacillus anthracis capsule synthesis via acpA and a newly discovered regulator, acpB. J Bacteriol. 186: 307-315. (Pubitemid 38076419)
35. Green, B. D., L. Battisti, T. M. Koehler, C. B. Thorne, and B. E. Ivins. 1985. Demonstration of a capsule plasmid in Bacillus anthracis. Infect. Immun. 49: 291-297.
36. Steichen, C. T., J. F. Kearney, and C. L. Turnbough, Jr. 2005. Characterization of the exosporium basal layer protein BxpB of Bacillus anthracis. J. Bacteriol. 187: 5868-5876.
37. Pestonjamasp, V. K., K. H. Huttner, and R. L. Gallo. 2001. Processing site and gene structure for the murine antimicrobial peptide CRAMP. Peptides 22: 1643-1650.
38. Gudmundsson, G. H., B. Agerberth, J. Odeberg, T. Bergman, B. Olsson, and R. Salcedo. 1996. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J. Biochem. 238: 325-332.
39. Zhao, C., L. Liu, and R. I. Lehrer. 1994. Identification of a new member of the protegrin family by cDNA cloning. FEBS Lett. 346: 285-288. (Pubitemid 24185620)
40. Steinberg, D. A., and R. I. Lehrer. 1997. Designer assays for antimicrobial peptides: disputing the "one-size-fits-all" theory. Methods Mol. Biol. 78: 169-186.
41. Swiecki, M. K., M. W. Lisanby, F. Shu, C. L. Turnbough, Jr., and J. F. Kearney. 2006. Monoclonal antibodies for Bacillus anthracis spore detection and functional analyses of spore germination and outgrowth. J. Immunol. 176: 6076-6084.
42. Oliva, C. R., M. K. Swiecki, C. E. Griguer, M. W. Lisanby, D. C. Bullard, C. L. Turnbough, Jr., and J. F. Kearney. 2008. The integrin Mac-1 (CR3) mediates internalization and directs Bacillus anthracis spores into professional phagocytes. Proc. Natl. Acad. Sci. USA 105: 1261-1266.
43. Ezzell, J. W., Jr., T. G. Abshire, S. F. Little, B. C. Lidgerding, and C. Brown. 1990. Identification of Bacillus anthracis by using monoclonal antibody to cell wall galactose-N-acetylglucosamine polysaccharide. J. Clin. Microbiol. 28: 223-231.
44. Oliver, A. M., J. C. Grimaldi, M. C. Howard, and J. F. Kearney. 1999. Independently ligating CD38 and FcγRIIB relays a dominant negative signal to B cells. Hybridoma 18: 113-119.
45. Kristian, S. A., A. M. Timmer, G. Y. Liu, X. Lauth, N. Sal-Man, Y. Rosenfeld, Y. Shai, R. L. Gallo, and V. Nizet. 2007. Impairment of innate immune killing mechanisms by bacteriostatic antibiotics. FASEB J. 21: 1107-1116.
46. Turner, J., Y. Cho, N. N. Dinh, A. J. Waring, and R. I. Lehrer. 1998. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 42: 2206-2214. (Pubitemid 28420351)
47. Heninger, S., M. Drysdale, J. Lovchik, J. Hutt, M. F. Lipscomb, T. M. Koehler, and C. R. Lyons. 2006. Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax. Infect. Immun. 74: 6067-6074. (Pubitemid 44657384)
48. Drysdale, M., S. Heninger, J. Hutt, Y. Chen, C. R. Lyons, and T. M. Koehler. 2005. Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax. EMBO J. 24: 221-227. (Pubitemid 40188479)
49. Brogden, K. A., V. C. Kalfa, M. R. Ackermann, D. E. Palmquist, P. B. McCray, Jr., and B. F. Tack. 2001. The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection. Antimicrob. Agents Chemother. 45: 331-334.
50. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415: 389-395.
51. Harvill, E. T., G. Lee, V. K. Grippe, and T. J. Merkel. 2005. Complement depletion renders C57BL/6 mice sensitive to the Bacillus anthracis Sterne strain. Infect. Immun. 73: 4420-4422.
52. Loving, C. L., M. Kennett, G. M. Lee, V. K. Grippe, and T. J. Merkel. 2007. Murine aerosol challenge model of anthrax. Infect. Immun. 75: 2689-2698.
53. Welkos, S. L., and A. M. Friedlander. 1988. Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis. Microb. Pathog. 4: 53-69.
54. Bowdish, D. M., D. J. Davidson, Y. E. Lau, K. Lee, M. G. Scott, and R. E. Hancock. 2005. Impact of LL-37 on anti-infective immunity. J. Leukocyte Biol. 77: 451-459.
55. Welkos, S. L., R. W. Trotter, D. M. Becker, and G. O. Nelson. 1989. Resistance to the Sterne strain of B. anthracis: phagocytic cell responses of resistant and susceptible mice. Microb. Pathog. 7: 15-35.
56. Kurosaka, K., Q. Chen, F. Yarovinsky, J. J. Oppenheim, and D. Yang. 2005. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J. Immunol. 174: 6257-6265. (Pubitemid 40663818)
57. Fisher, N., L. Shetron-Rama, A. Herring-Palmer, B. Heffernan, N. Bergman, and P. Hanna. 2006. The dltABCD operon of Bacillus anthracis Sterne is required for virulence and resistance to peptide, enzymatic, and cellular mediators of innate immunity. J. Bacteriol. 188: 1301-1309. (Pubitemid 43228663)
58. Radyuk, S. N., P. A. Mericko, T. G. Popova, E. Grene, and K. Alibek. 2003. In vitro-generated respiratory mucosa: a new tool to study inhalational anthrax. Biochem. Biophys. Res. Commun. 305: 624-632.
59. Thwaite, J. E., S. Hibbs, R. W. Titball, and T. P. Atkins. 2006. Proteolytic degradation of human antimicrobial peptide LL-37 by Bacillus anthracis may contribute to virulence. Antimicrob. Agents Chemother. 50: 2316-2322.
60. Campos, M. A., M. A. Vargas, V. Regueiro, C. M. Llompart, S. Alberti, and J. A. Bengoechea. 2004. Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect. Immun. 72: 7107-7114.
61. Kristian, S. A., V. Datta, C. Weidenmaier, R. Kansal, I. Fedtke, A. Peschel, R. L. Gallo, and V. Nizet. 2005. D-Alanylation of teichoic acids promotes group a Streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion. J. Bacteriol. 187: 6719-6725.
62. Wartha, F., K. Beiter, B. Albiger, J. Fernebro, A. Zychlinsky, S. Normark, and B. Henriques-Normark. 2007. Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps. Cell Microbiol. 9: 1162-1171. (Pubitemid 46547136)
63. Kalfa, V. C., H. P. Jia, R. A. Kunkle, P. B. McCray, Jr., B. F. Tack, and K. A. Brogden. 2001. Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells. Antimicrob. Agents Chemother. 45: 3256-3261.
64. Oren, Z., J. C. Lerman, G. H. Gudmundsson, B. Agerberth, and Y. Shai. 1999. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem. J. 341(Pt. 3): 501-513. (Pubitemid 29389178)
65. Ouhara, K., H. Komatsuzawa, T. Kawai, H. Nishi, T. Fujiwara, Y. Fujiue, M. Kuwabara, K. Sayama, K. Hashimoto, and M. Sugai. 2008. Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus. J. Antimicrob. Chemother. 61: 1266-1269. (Pubitemid 351753592)
66. Zanetti, M. 2005. The role of cathelicidins in the innate host defenses of mammals. Curr. Issues Mol. Biol. 7: 179-196. (Pubitemid 41051685)
67. Tran, D., P. Tran, K. Roberts, G. Osapay, J. Schaal, A. Ouellette, and M. E. Selsted. 2008. Microbicidal properties and cytocidal selectivity of rhesus macaque θ defensins. Antimicrob. Agents Chemother. 52: 944-953.
68. Cirioni, O., A. Giacometti, R. Ghiselli, C. Bergnach, F. Orlando, C. Silvestri, F. Mocchegiani, A. Licci, B. Skerlavaj, M. Rocchi, et al. 2006. LL-37 protects rats against lethal sepsis caused by Gram-negative bacteria. Antimicrob. Agents Chemother. 50: 1672-1679.
69. Stein, O., Y. Dabach, M. Ben-Naim, G. Halperin, and Y. Stein. 2006. Lower macrophage recruitment and atherosclerosis resistance in FVB mice. Atherosclerosis 189: 336-341. (Pubitemid 44634498)
70. Stevenson, M. M., P. A. Kongshavn, and E. Skamene. 1981. Genetic linkage of resistance to Listeria monocytogenes with macrophage inflammatory responses. J. Immunol. 127: 402-407.
71. Henderson, D. W., S. Peacock, and F. C. Belton. 1956. Observations on the prophylaxis of experimental pulmonary anthrax in the monkey. J. Hyg. 54: 28-36.
72. Lyons, C. R., J. Lovchik, J. Hutt, M. F. Lipscomb, E. Wang, S. Heninger, L. Berliba, and K. Garrison. 2004. Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility. Infect. Immun. 72: 4801-4809.
73. Glomski, I. J., A. Piris-Gimenez, M. Huerre, M. Mock, and P. L. Goossens. 2007. Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax. PLoS Pathog. 3: e76.
74. Brown, K. 2001. Anthrax: a "sure killer" yields to medicine. Science 294: 1813-1814.
75. Reissman, D. B., E. A. Whitney, T. H. Taylor, Jr., J. A. Hayslett, P. M. Dull, I. Arias, D. A. Ashford, E. A. Bresnitz, C. Tan, N. Rosenstein, and B. A. Perkins. 2004. One-year health assessment of adult survivors of Bacillus anthracis infection. J. Am. Med. Assoc. 291: 1994-1998.